These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 20538722

  • 21. Hepatobiliary transport of a nonpeptidic endothelin antagonist, (+)-(5S,6R,7R)-2-butyl-7-[2((2S)-2-carboxypropyl)-4-methoxyphenyl]-5-(3,4-methylenedioxyphenyl) cyclopentenol[1,2-b]pyridine-6-carboxylic acid: uptake by isolated rat hepatocytes and canalicular membrane vesicles.
    Kobayashi N, Tani T, Hisaka A, Hara K, Yasumori T.
    Pharm Res; 2003 Jan; 20(1):89-95. PubMed ID: 12608541
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Vectorial transport of bile salts across MDCK cells expressing both rat Na+-taurocholate cotransporting polypeptide and rat bile salt export pump.
    Mita S, Suzuki H, Akita H, Stieger B, Meier PJ, Hofmann AF, Sugiyama Y.
    Am J Physiol Gastrointest Liver Physiol; 2005 Jan; 288(1):G159-67. PubMed ID: 15297262
    [Abstract] [Full Text] [Related]

  • 25. Hepatic transport of PKI166, an epidermal growth factor receptor kinase inhibitor of the pyrrolo-pyrimidine class, and its main metabolite, ACU154.
    Takada T, Weiss HM, Kretz O, Gross G, Sugiyama Y.
    Drug Metab Dispos; 2004 Nov; 32(11):1272-8. PubMed ID: 15280219
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Quantitative time-lapse imaging-based analysis of drug-drug interaction mediated by hepatobiliary transporter, multidrug resistance-associated protein 2, in sandwich-cultured rat hepatocytes.
    Nakanishi T, Shibue Y, Fukuyama Y, Yoshida K, Fukuda H, Shirasaka Y, Tamai I.
    Drug Metab Dispos; 2011 Jun; 39(6):984-91. PubMed ID: 21415249
    [Abstract] [Full Text] [Related]

  • 28. Transport mechanisms of hepatic uptake and bile excretion in clinical hepatobiliary scintigraphy with 99mTc-N-pyridoxyl-5-methyltryptophan.
    Kobayashi M, Nakanishi T, Nishi K, Higaki Y, Okudaira H, Ono M, Tsujiuchi T, Mizutani A, Nishii R, Tamai I, Arano Y, Kawai K.
    Nucl Med Biol; 2014 Apr; 41(4):338-42. PubMed ID: 24607436
    [Abstract] [Full Text] [Related]

  • 29. Saturation of multidrug-resistant protein 2 (mrp2/abcc2)-mediated hepatobiliary secretion: nonlinear pharmacokinetics of a heterocyclic compound in rats after intravenous bolus administration.
    Hu Y, Sampson KE, Heyde BR, Mandrell KM, Li N, Zutshi A, Lai Y.
    Drug Metab Dispos; 2009 Apr; 37(4):841-6. PubMed ID: 19139164
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The hepatobiliary disposition of timosaponin b2 is highly dependent on influx/efflux transporters but not metabolism.
    Sheng J, Tian X, Xu G, Wu Z, Chen C, Wang L, Pan L, Huang C, Pan G.
    Drug Metab Dispos; 2015 Jan; 43(1):63-72. PubMed ID: 25336752
    [Abstract] [Full Text] [Related]

  • 32. Involvement of multiple transporters in the hepatobiliary transport of rosuvastatin.
    Kitamura S, Maeda K, Wang Y, Sugiyama Y.
    Drug Metab Dispos; 2008 Oct; 36(10):2014-23. PubMed ID: 18617601
    [Abstract] [Full Text] [Related]

  • 33. Carrier-mediated hepatobiliary transport of a novel antifolate, N-[4-[(2,4-dianninopteridine-6-yl)methyl]-3,4-dihydro-2H-1,4-benzothiazin-7-yl]carbonyl-L-homoglutamic acid, in rats.
    Han YH, Kato Y, Watanabe Y, Terao K, Asoh Y, Sugiyama Y.
    Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):394-400. PubMed ID: 11259322
    [Abstract] [Full Text] [Related]

  • 34. Primary active transport of pravastatin across the liver canalicular membrane in normal and mutant Eisai hyperbilirubinaemic rats.
    Yamazaki M, Kobayashi K, Sugiyama Y.
    Biopharm Drug Dispos; 1996 Nov; 17(8):645-59. PubMed ID: 8950045
    [Abstract] [Full Text] [Related]

  • 35. Down-regulation of organic anion transporter expression in human hepatocytes exposed to the proinflammatory cytokine interleukin 1beta.
    Le Vee M, Gripon P, Stieger B, Fardel O.
    Drug Metab Dispos; 2008 Feb; 36(2):217-22. PubMed ID: 17991769
    [Abstract] [Full Text] [Related]

  • 36. Primary active transport of pravastatin across the liver canalicular membrane in normal and mutant Eisai hyperbilirubinemic rats.
    Yamazaki M, Kobayashi K, Sugiyama Y.
    Biopharm Drug Dispos; 1996 Oct; 17(7):607-21. PubMed ID: 8894118
    [Abstract] [Full Text] [Related]

  • 37. Hepatobiliary disposition in primary cultures of dog and monkey hepatocytes.
    Rose KA, Kostrubsky V, Sahi J.
    Mol Pharm; 2006 Oct; 3(3):266-74. PubMed ID: 16749858
    [Abstract] [Full Text] [Related]

  • 38. Pharmacokinetic analysis of ramatroban using a recirculatory model with enterohepatic circulation by measuring portal and systemic blood concentration difference in Sprague-Dawley and Eisai hyperbilirubinemic rats.
    Moriwaki T, Yasui H, Yamamoto A.
    Pharm Res; 2004 Jun; 21(6):1055-64. PubMed ID: 15212172
    [Abstract] [Full Text] [Related]

  • 39. An experimental approach to evaluate the impact of impaired transport function on hepatobiliary drug disposition using Mrp2-deficient TR- rat sandwich-cultured hepatocytes in combination with Bcrp knockdown.
    Yang K, Pfeifer ND, Hardwick RN, Yue W, Stewart PW, Brouwer KL.
    Mol Pharm; 2014 Mar 03; 11(3):766-75. PubMed ID: 24410402
    [Abstract] [Full Text] [Related]

  • 40. Hepatic basolateral efflux contributes significantly to rosuvastatin disposition II: characterization of hepatic elimination by basolateral, biliary, and metabolic clearance pathways in rat isolated perfused liver.
    Pfeifer ND, Bridges AS, Ferslew BC, Hardwick RN, Brouwer KL.
    J Pharmacol Exp Ther; 2013 Dec 03; 347(3):737-45. PubMed ID: 24080682
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.